Proteomic and Mass Spectrometry Technologies for Biomarker Discovery - Proteomic and Metabolomic Approaches to Biomarker Discovery - page 34

27. Sedlaczek P, Frydecka I, Gabrys M, Van Dalen A,
Einarsson R, Harlozinska A. Comparative analysis of
CA125,

proteome under 50 kDa by molecular-mass-based
fractionation and top-down mass spectrometry. Anal
Chem 2012; c antigen, and

soluble interleukin-2 receptor alpha levels in sera, cyst,
and ascitic

tissue polypeptide speci (1):209 e 15.

42. Northrop JH, Kunitz M. Isolation of protein crystals
possessing tryptic activity. Science 1931;

84

fluids from patients with ovarian carci-
noma. Cancer 2002;

(1888):262 e 3.
43. Swaney DL, Wenger CD, Coon JJ. Value of using
multiple proteases for large-scale mass spectrometry-
based proteomics. J Proteome Res 2010;

73

(9):1886 e 93.
28. Teng PN, Bateman NW, Hood BL, Conrads TP.
Advances in proximal

95

fluid proteomics for disease (3):1323 e 9.

44. Shevchenko A, Jensen ON, Podtelejnikov AV,
Sagliocco F, Wilm M, Vorm O, et al. Linking genome
and proteome by mass spectrometry:

9

biomarker discovery. J Proteome Res 2010; 9 (12):

6091 e 100.
29. Kondo T. Tissue proteomics for cancer biomarker
development:

large-scale

laser microdissection and 2D-DIGE. identi cation of yeast proteins from two dimensional

gels. Proc Natl Acad Sci U S A 1996; (9):626 e 34.

30. Good DM, Thongboonkerd V, Novak J, Bascands JL,
Schanstra JP, Coon JJ, et al. Body

BMB Rep 2008; 41 (25):14440 e 5.

45. Clauser KR, Hall SC, Smith DM, Webb JW,
Andrews LE, Tran HM, et al. Rapid mass spectro-
metric peptide sequencing and mass matching for
characterization of human melanoma proteins isolated
by two-dimensional PAGE. Proc Natl Acad Sci U S A
1995;

93

fluid proteomics for
biomarker discovery: lessons from the past hold the
key to success in the future. J Proteome Res 2007; 6 (12):

4549 e 55.
31. Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D,
Naven T, et al. The potential use of laser capture
microdissection to selectively obtain distinct pop-
ulations of cells for proteomic analysis d preliminary

(11):5072 e 6.
46. Washburn MP, Wolters D, Yates 3rd JR. Large-scale
analysis of the yeast proteome by multidimensional
protein identi

92

cation technology. Nat Biotechnol 2001;

(4-5):689 e 700.
32. Gutstein HB, Morris JS. Laser capture sampling and
analytical issues in proteomics. Expert Rev Proteomics
2007;

findings. Electrophoresis 1999; 20 (3):242 e 7.

47. Drabovich AP, Pavlou MP, Dimitromanolakis A,
Diamandis EP. Quantitative analysis of energy meta-
bolic pathways in MCF-7 breast cancer cells by
selected reaction monitoring assay. Mol Cell Proteomics
2012;

19

(5):627 e 37.
33. Soto AM, Sonnenschein C. Emergentism as a default:
cancer as a problem of tissue organization. J Biosci
2005;

4

:422 e 34.
48. Karas M, Bachmann D, Bahr U, Hillenkamp F. Matrix-
assisted ultraviolet laser desorption of non-volatile
compounds. Int J Mass Spectrom Ion Processes 1987;
78

11

(1):103 e 18.
34. Ralton LD, Murray GI. The use of formalin

30

xed wax
embedded tissue for proteomic analysis. J Clin Pathol
2011; (4):297 e 302.

35. Kulasingam V, Diamandis EP. Tissue culture-based
breast cancer biomarker discovery platform.

64 (0):53 e 68.

49. Fenn JB, Mann M, Meng CK, Wong SF,
Whitehouse CM. Electrospray ionization for mass
spectrometry of

Int J

(9):2007 e 12.
36. Frese KK, Tuveson DA. Maximizing mouse cancer
models. Nat Rev Cancer 2007;

Cancer 2008; 123 large biomolecules. Science 1989;

(4926):64 e 71.
50. Alexander AJ, Hughes DE. Monitoring of IgG anti-
body thermal stability by micellar electrokinetic
capillary chromatography and matrix-assisted laser
desorption/ionization mass spectrometry. Anal Chem
1995;

246

(9):645 e 58.
37. Ransohoff DF, Gourlay ML. Sources of bias in speci-
mens for research about molecular markers for cancer.
J Clin Oncol 2010;

7

(4):698 e 704.
38. Hinestrosa MC, Dickersin K, Klein P, Mayer M,
Noss K, Slamon D, et al. Shaping the future of
biomarker research in breast cancer to ensure clinical
relevance. Nat Rev Cancer 2007;

28

(20):3626 e 32.
51. Caprioli RM, Farmer TB, Gile J. Molecular imaging of
biological samples: localization of peptides and
proteins using MALDI-TOF MS. Anal Chem 1997;
69

67

(4):309 e 15.
39. Vaught JB, Caboux E, Hainaut P. International efforts
to develop biospecimen best practices. Cancer Epi-
demiol Biomarkers Prev 2010;

7

(23):4751 e 60.
52. Schwamborn K, Caprioli RM. Molecular imaging
by mass spectrometry d looking beyond classical
histology. Nat Rev Cancer 2010;

(4):912 e 5.
40. Tran JC, Zamdborg L, Ahlf DR, Lee JE,
Catherman AD, Durbin KR, et al. Mapping intact
protein isoforms in discovery mode using top-down
proteomics. Nature 2011;

19

(9):639 e 46.
53. Michalski A, Damoc E, Hauschild JP, Lange O,
Wieghaus A,MakarovA, et al.Mass spectrometry-based
proteomics using Q Exactive, a high-performance
benchtop quadrupole Orbitrap mass spectrometer. Mol
Cell Proteomics 2011;

10

(7376):254 e 8.
41. Kellie JF, Catherman AD, Durbin KR, Tran JC,
Tipton JD, Norris JL, et al. Robust analysis of the yeast

480

10 (9). M111.011015.